Skip to main content
Fig. 3 | Journal of Nanobiotechnology

Fig. 3

From: Combination therapy based on dual-target biomimetic nano-delivery system for overcoming cisplatin resistance in hepatocellular carcinoma

Fig. 3

Characterization of AR-NADR. A TEM images of (a) Ag-MOF (b) NLS-Ag-MOF (c) NADR, (d) AR and (e) AR-NADR (Scale bar:100 nm). B Nanoparticle size and C zeta potential of Ag-MOF, NLS-Ag-MOF, NADR, AR, and AR-NADR. D XRD patterns of Ag-MOF. E FTIR spectra of AgNO3, L- histidine and Ag-MOF. F UV–vis spectra of NLS-Ag-MOF (NA), Cisplatin (DDP), A54-RBCm (AR), NOR1shRNA (R) and AR-NADR. G Profiles of membrane proteins in AR, NADR and AR-NADR by SDS-PAGE analysis. Data are presented as means ± SD (n = 3)

Back to article page